NHL
Showing NaN - NaN of 5
Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab
Withdrawn
- Non Hodgkin's Lymphoma
- +3 more
- Veltuzumab and 90Y-Epratuzumab Tetraxetan
- +2 more
-
Newark, Delaware
- +6 more
Aug 12, 2021
NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)
Completed
- NHL
- +17 more
- veltuzumab
-
Savannah, Georgia
- +4 more
Aug 12, 2021